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Cyclosporin A reduces proteinuria in adriamycin nephropathy in the
rat. J.F. Desassis, J. van den Born, J.H.M. Berden, Division of
Nephrology, University Hospital, N,jmegen, The Netherlands, The
anti-proteinuric effect of cyclosporin A (CsA) was studied in an
experimental model of minimal change disease. Four weeks after i.v.
administration of adriamycin (ADR; 5 mg/kg body wt) in male Wistar
rats a stable albuminuria develops. From day 30 to day 35 rats were
treated orally with either CsA (20 mg/kg body wt, N 10) or olive oil(00, N = 10). Urinary excretion of albumin (Ualb) and IgG was
measured in 24 hours urine at day 28 and day 34. Selectivity index (SI,
CIgO/Caib) was calculated before and after treatment. Glomerular filtra-
tion rate (GFR) was measured by the 51Cr-EDTA method at day 29 and
day 35 and used for the calculation of the fractional excretion of
albumin (FEab). Results (mean SD) are shown in the table. With the
unpaired Wilcoxon no differences were found between 00 and CsA
before treatment; P values after treatment with 00 and CsA are given.
was primarily located in LDL1, LDL2 and HDL2 lipoproteins. Plasma
apolipoprotein (apo) A-I was increased by more than 400% in ADR rats
(P < 0.001). Apo B andapo Ewere increased by about 60% (P < 0.01).
Apo A-IV remained unchanged. Both in rats with experimental NS
induced by low-dose ADR and controls, circulating cholesterol was
largely (±70%) transported in apo A-I and apo E-rich particles. Focal
sclerotic lesions had an incidence of 50 10% in ADR rats versus 2
1% in controls (P < 0.001). Renal localization of apolipoproteins and
lipids was evaluated using immunohistochemistry and Oil Red 0
staining, respectively. Apo A-I and apo A-lV were found in glomerular
visceral epithelial cells and deposits of apo E in focal sclerotic lesions of
glomeruli of ADR rats. Lipid was only detected in focal lesions. Neither
apolipoproteins nor lipid deposits were detected in glomeruli of con-
trols. Proteinuria induced by a single low dose of ADR in rats is a
promising model for study of the alleged pathogenetic role of hyperlip-
idemia and abnormal lipoprotein composition in the deterioration of
renal function and morphology in chronic NS.
P
UaIb 434 400 409 274 <0.001
mg/24/hrs 100 75 95 36
GFR 1.43 1.44 1.52 0.84 <0.001
ml/min 0.25 0.35 0.3l 0.16
FEalb 5.01 5.50 4.45 3.21 <0.002
% 2.99 2.14 2.32 1.46
SI 0.17
0.06
0.15
0.05
0.17
0.05
0.11 0.198
<0.0?
In conclusion: (I) CsA is anti-proteinuric in ADR nephropathy; (2) This
is not only due to a reduction of the GFR but also to changes in the
permselectivity of the GBM.
Plasma lipoprotein composition and glomerular apolipoprotein and
lipid distribution in rats with chronic nephrotic syndrome induced by a
single low dose of adriamycin. J.A. Joles, H. van Goor, J. Grond, A.J.
Rabelink, H.A. Koomans, E.H.J.M. Jansen, and A. van Tol, Depart-
ment of Nephrology, University of Utrecht, Department of Pathology,
University of Groningen, Laboratory of Toxicology, National Institute
of Public Health, Bilthoven and Department of Biochemistry, Erasmus
University, Rotterdam, The Netherlands. Hyperlipidemia may play a
role in the decline of renal function in chronic nephrotic syndrome
(NS). Puromycin aminonucleoside and passive Heymann models of NS
are transient, and high doses of adriamycin (ADR) cause renal failure.
Thus, these models are not suitable for chronic studies. Plasma lipo-
protein and apolipoprotein (apo) composition was studied in rats in
which renal function and plasma lipids had been monitored for seven
months after a single low dose of ADR (3 mg/kg i.v.). Proteinuria was
observed three weeks after ADR and increased progressively up to 0.5
g/day (vs. 0.07 g/day in controls; P < 0.001), while the creatinine
clearance remained stable at about 80% of control levels. Hypercho-
lesterolemia, observed six weeks after ADR increasing progressively up
to 7.0 1.0 mmol/liter(vs. 2.3 0.1 mmol/liter in controls; P <0.001),
An animal model for human preeclampsia: Ultra-low dose endotoxin
infusion in conscious pregnant rats. MM. Faas, J.F. W. Baller, P.A.
Kiok, G.A. Schuiling, and W.W. Bakker, Departments of Pathology
and Obstetrics and Gynecology, University Hospital Groningen, Gron-
ingen, The Netherlands. Clinical symptoms characteristic for human
preeclampsia involve hypertension and proteinuria, whereas diffuse
intravascular coagulation (DIC) may also occur. The pathophysiology
of this disorder is unknown, while up till now suitable animal models
were lacking. In the present study we developed an ultra low-dose
endotoxin infusion protocol in conscious pregnant rats via a permanent
jugular vein canula. Fourteen days after conception pregnant rats (N =
10) were infused with 2 ml endotoxin in saline (B-rats; E-coli, 0.55:B5;
I jxg/kg body wt; infusion rate: 2 ml/hr). Control pregnant rats (N = 6)
were infused with 2 ml pyrogen free saline (C-rats) under identical
conditions. At day 21 rats were sacrificed and kidneys were prepared
for immunohistology and enzyme histochemistry. Arterial blood pres-
sure (tail-cuff method) and 24 hour urinary albumin excretion were
assayed (days 15 and 19) using standard methods, whereas glomerular
filtration rate (GFR) was measured using the 51Cr-EDTA method. The
intra-glomerular thrombotic tendency was evaluated in kidney sections
by quantification of ADP-ase activity using standard image analyzing
techniques and expressed as an index, whereas intra-glomerular fibrin-
ogen depositions were semi-quantitatively evaluated by direct fluores-
cence using FITC-conjugated rabbit-anti-rat fibrinogen. The following
is a summary of physiological results one day after infusion and two
days before sacrifice.
C-rats B-rats
Day IS Day 19
125.3 1.9
366 78
Day
128.1
918
15
1.6
l20
-
Day 19
131.3 l.6a
960 l74'
Blood pressure
mm Hg
24 hr albumin
129.6 2.1
294 66
p-g
GFR mI/mm 1.57 0.1 1.64 0.0 1.53 0.06 1.62 0.08
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Values mean SEM.
a
Mann-Whitney-U-test, P < 0.05 vs. C-rats
00 CsA
Before After Before After
a p values (paired Wilcoxon's) before and after CsA treatment.
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As shown in the table, blood pressure as well as albumin excretion of
E-rats was increased compared to C-rats, while the GFR did not
significantly change. A significant decrease of the glomerular ADP-ase
activity occurred in E-rats as compared with C-rats (40.6 4.7 vs. 27.9
4.0, mean SEM, Mann-Whitney-U-test, P < 0.05) and only E-rats
showed significant glomerular fibrinogen depositions. Since the present
preeclamptic-like model displays both clinical symptoms as well as
glomerular alteration similar to the human counterpart, further investi-
gation into this experimental disorder may increase our understanding
of the pathophysiology of human preeclampsia.
Autoamplification of systemic autoimmunity by anti-CD26 autoanti-
bodies in experimental lupus nephritis in mice. E. De Heer, E.H.G. Van
Leer, G. De Roo, H. Baelde, J.A. Bru,jn, Ph.J. Hoedemaeker, Depart-
ment of Pathology, University of Leiden, The Netherlands. Chronic
graft-versus-host disease (GvH) can be induced by transfer of lympho-
cytes from DBA/2 mice to (DBA/2 x C57BI1O) Fl hybrids. The
resulting lupus-like disease is characterized by a nephrotic syndrome, in
which autoantibodies against nuclear antigens, basement membrane
components and epithelial glycoproteins play a role. One epithelial
autoantigen involved is shared with T lymphocytes: dipeptidyl peptid-
ase type IV (DPP LV), which is identical to CD26, an important T-cell
activation marker. In this study we investigated the immunomodulatory
role of autoantibodies against CD26 by FACS analysis. Circulating T
lymphocytes became transiently CD26, leading to the disappearance
of this marker from 60% of T cells at four to six weeks after the
induction of GvH, followed by a reappearance of CD26 from 10 weeks
onwards. In vitro, however, T cells from mice with GvH harvested at
six to eight weeks after induction demonstrated a significantly higher
proliferative response to solid-phase anti-CD3, as compared to normal
T cells. This increased responsiveness could be mimicked in vitro by
overnight incubation of normal T cells with anti-CD26 antibodies,
followed by stimulation with solid-phase anti-CD3. Double label flow-
cytometry analysis of mouse T cells showed a close association of CD26
with the epsilon chain of CD3. This study shows that anti-CD26
autoantibodies induced in vivo modulation of this marker from T
lymphocytes, resulting in an increased responsiveness of these cells for
stimulation through the T cells receptor/CD3 complex and may reflect
an auto-amplification pathway of systemic autoimrnune disease by
anti-leukocyte antibodies.
Renal perfusion of myeloperoxidase in myeloperoxidase immunized
brown norway (BN) rats. E. Brouwer, J.J. Weening, P.A. KLok, M.G.
Huitema, J.W. Cohen Tervaert, C.G.M. Kallenberg, Department of
Clinical Immunology and Pathology, University Hospital Groningen
and Amsterdam. In order to develop a model for studying the patho-
genetic potential of the MPO directed immune response, we immunized
BN rats with purified human myeloperoxidase in sodiumacetate (NaAc)
buffer or NaAc alone in CFA supplemented with H37Ra. Three
protocols were followed: (I) MPO immunization, LPS treatment and
MPO perfusion (N = 6) (2) MPO immunization, saline treatment and
MPO perfusion (N = 6) (3) NaAc immunization, LPS treatment and
MPO perfusion (N = 6). Treatment with lipopolysaccharide (LPS) i.p.
twice a week for five weeks was chosen in order to activate both
neutrophils and endothelial cells, based on the assumption that infec-
tions play a major role in the induction of vasculitis/glomerulonephritis.
LPS treatment did not result in the development of anti-glomerular
basement membrane antibodies. After LPS or saline treatment we
perfused the left kidney in a closed blood-free circuit with human MPO.
After perfusion, the blood circulation was restored and the rats from
groups 1, II and III were sacrificed at 24 hours, four and 10 days,
respectively, after renal perfusion with MPO. At sacrifice we deter-
mined levels of anti-MPO antibodies, 24 hours urine-protein excretion,
and we processed both kidneys for immunohistochemistry.
24 hours 4 days 10 days
Group mq' pmn ab mq pmn ab mçb pmn ab
3.4 2.4 130 15.7 6.6 536 27.1 4.6 205
11 1.6 2.4 120 9.5 4.3 346 21.4 2.5 136
ILL 1.2 0.2 0 2.8 0.3 0 5.4 0.7 0
m4(EDI); macrophages/pmn(his48); neutrophils; mean/glomerulus
ab; anti-MPO antibodies detected in a solid phase ELISA (U of
standard)
MPO was present along the GBM shortly after perfusion and induced a
transient toxic effect as shown in group III. IgG and complement were
present along the GBM until 24 hours in group I and Il. The presence of
mcb and PMN's persisted in group I and II. In addition, granulomatous
and vascular lesions were found in group I and LI. We conclude that the
present model enables the study of the role of the MPO directed
immune response in the pathogenesis of ON and vasculitis.
The clinical significance of allo specific antibodies against endothelial
cells detected with an antibody-dependent cellular cytotoxicity (ADCC)
assay for vascular rejection. BA. Yard, F. Claas, J. Thorogood, J.A.
Bru,jn, M.E. Paape, L.A. Van Es, J.H. van Bockel, M. Kooymans-
Couthino, M.R. Daha, and F.J. van der Woude, Department of
Nephrology, University Hospital, Leiden, The Netherlands. Vascular
or chronic rejection is thought to be mediated by antibodies bound to
endothelial cells (EC) causing damage to the lineage. However, rela-
tively little is known about the target antigens on EC responsible for the
immune damage. In this study, serum samples of 64 consecutive renal
transplant patients were analyzed for ADCC activity against human
umbilical vein endothelial cells (HUVEC). Serum samples were ob-
tained immediately before transplantation and one week, one month,
and one year after transplantation. The results were evaluated in the
context of classical tests to measure donor-specific immunity and
related to parameters of presensitization, graft survival and histology.
There was a highly significant correlation between ADCC positivity and
vascular rejection (P = 0.015). ADCC positivity did not correlate with
primary non-function, the number of rejection episodes or with inter-
stitial rejection. Graft survival was better in the ADCC negative than in
the positive group (P = 0.0004). Although there was a difference in graft
survival between the high sensitized (PRA > 85%) and low sensitized
(PRA < 85%) group, this did not reach statistical significance. From
these data we conclude that the anti-EC ADCC has a higher sensitivity
than PRA or lymphocyte/monocyte crossmatches for graft survival and
vascular rejection. Under the current organ exchange policy, antibodies
against this newly defined type of alloantigens seem to have greater
clinical relevance than anti-HLA antibodies.
Apolipoproteins in experimental nephrotic syndrome. H. van Goor,
M.L.C. van der Horst, J. Admosoerodjo, J.A. Joles, A. van Tol, J.
Grond, Department of Pathology, University of Groningen, Depart-
ment of Nephrology, University of Utrecht, Department of Biochemis-
t,y, Erasmus University Rotterdam, The Netherlands. Recent experi-
mental data suggest a role for lipoproteins in the pathogenesis of
glomeruloscierosis. In rats, cholesterol and its esters are transported
mainly in HDL. In this study we examined three major apolipoproteins
of HDL (A-I, A-IV, and E) in plasma and kidney tissue eight days after
induction of the nephrotic syndrome by puromycin aminonucleoside(PAN, N = 5, 6 mg/lOO g body wt). Total serum cholesterol was
significantly elevated in PAN [4.7 (3.0 to 5.3) mmol/liter] rats, compared
to control rats [C, N = 5, 2.1 (2.0 to 2.5) mmol/liter, P < .01]. Plasma
apolipoproteins were measured by electroimmunoassay. Apo A-I was
significantly elevated in PAN [121 (64 to 129) mg%] compared to C [35
(28 to 41) mg%, P < .011. No differences were observed for apo A-IV:
PAN [10(4 to 11) mg%], and C [8(6 to 9) mg%], and for apo E: PAN
[22 (18 to 34) mg%I, C [16 (13 to 22) mg%]. Immunohistological studies
using antibodies directed to apo A-I, apo A.LV, and apo E in plastic
sections revealed a massive increase of apo A-I immunoreactivity and
a slight increase of apo A-lV and apo E immunoreactivity in glomerular
visceral epithelial cells in PAN rats compared to C rats. Immunoelec-
tronmicroscopical (IEM) studies confirmed the presence of apo's in
these cells. In addition, large amounts of apo E were located in the
mesangium of PAN nephrotic rats. Double immunohistological staining
procedures revealed that apo E was predominantly present on the
surface of foamy EDI + mesangial macrophages. Using double JEM (5
and 15 nm gold particles) apo E was found in large amounts in the
mesangial matrix surrounding EDl foam cells. In proximal tubular
epithelial cells all apo's were found in a granular pattern in C rats with
increased immunoreactivity in PAN rats. Using LEM, these granules
appeared to be endocytotic vesicles and lysosomes. In conclusion,
nephrosis induced by PAN results in: (I) increased plasma levels of apo
A-I with concomitant enhanced deposition of this apoprotein in glomer-
ular visceral epithelial cells, (2) increased tubular localization of apo
Uprot
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A-I, apoA-IVand apo E, and (3) increased mesangial deposition of apo
E in close proximity to foamy macrophages.
The role and function of 5-hydroxytryptamine receptors in the human
peripheral vascular bed and their interaction with noradrenaline. TA.
Bruning, P.C. Chang, P. VermeU, H.C.R. Brandenburg, G.J. Blauw,
P.A. van Zwieten, Departments of Nephrology and Hospital Phar-
macy, University Hospital Leiden, and Department of Pharmacother-
apy, Academic Medical Center, Amsterdam, The Netherlands. The
objective of the present study was to characterize the role of 5-HT
receptors, and the possible interactions between 5-HT and NA, in the
vascular bed of the forearm. The effects of 5-HT2 receptor blockade
(ketansenn 50 ng/kg/min i.a., ritanserin 500 ng/kglmin i.a.) and a2-
adrenoceptor blockade (yohimbine I sg/kg/min) on the interaction
between 5-HT and exogenous NA (0.3 to 10 nglkg/min i.a.) or endog-
enous NA (tyramine 0.1 to I tg/kg/min i.a., or lower body negative
pressure —10 to —40 mm Hg), and the effect of 5-HT3 blockade
(ondansetron or granisetron, both 0.3 and I zg/kg/min i.a.), were
assessed by means of venous occlusion plethysmography. Different
infusion protocols were conducted in normotensive volunteers (N  6).
"Flow control" infusions were performed using the vehicle alone or
sodium nitroprusside 3 or 5 ng/kg/min i.a.). 5-HT did not influence the
vasoconstriction caused by exogenous or endogenous NA, compared
with controls (dose response curves). The 5-HT3 antagonists on-
dansetron and granisertron did not significantly antagonize the vasodi-
lator response to 5-HT at the given dosages. Whereas the existence of
5-HT2 receptors in the forearm vascular bed is well established, that of
5-HT3 receptors seems uncertain. Serotonin does not potentiate NA-
induced vasoconstriction (in contrast to isolated blood vessels), thus
indicating that such a potentiation in the periphery cannot offer an
explanation for the antihypertensive effect of ketanserin.
A decrease in proteinuria during ACE inhibition (ACEi) is associated
with a better renal function outcome. Ron T. Gansevoort, Jan E. Heeg,
Alfred J. Apperloo, Dick de Zeeuw, Paul E. de Jong, Department of
Medicine, Division of Nephrology, University Hospital Groningen, The
Netherlands. in order to assess the effects of prolonged symptomatic
antiproteinuric treatment by ACEi in patients with nephrotic range
proteinuria, we studied 22 patients during a 1.5 year follow-up period.
Baseline characteristics of these patients are: female/male 5/17, age 38.8
2.4 year, histologic diagnosis 8 MGP/8 FGS/6 IgA, proteinuria 7.5
0.9 g/day, GFR 76.5 7.0 ml/min, mean arterial blood pressure (MAP)
103.1 3.5 mm Hg. After 2 months of ACEi, proteinuria was
significantly lowered from 7.5 0.9 to 2.9 0.5 g/day, which is well
maintained during the 1.5 year follow-up. Other parameters of the
nephrotic syndrome, such as elevated serum cholesterol and low serum
albumin, improved significantly.
1285
exists between the percentage decrease of proteinuria in individual
patients and their slope of the inverse serum creatinine (P < 0.001).
This suggests that a lower level of proteinuria might have a favorable
effect on renal function decline. This is supported by the finding that
remaining proteinuria at eight weeks ACEi is also correlated with the
decline in kidney function (P < 0.01). None of the pretreatment
parameters, such as proteinuria, MAP, GFR or FF, or the percentage
change during ACEI in these parameters, show a correlation with the
inverse creatinine slope. Although these data are difficult to interpret
because a control group is lacking, they suggest that a possible
renoprotective ability of ACEi could be caused by its proteinuria
lowering effect.
Ilematological complications of hantavirus nephropathy (HVN). J.
Clement, R. De Bock, Military Hospital Brussels, University Hospital
Antwerp (UZA) Belgium. Hantavirus (HV) is a newly recognized
rodent-borne hemorrhagic fever virus with a worldwide distribution.
HVN symptoms consist mostly of fever (t°) and acute renal failure
(ARF), as shown by two serologically confirmed HVN-patients admit-
ted at UZA in 1990. Both presented with to, lumbar pain, petechiae,
suffused palate and conjunctivae, and rapidly developing ARF. The
clinical course, however, was further complicated by normocytic,
normochromic anemia of rapid onset (8 to 10 days post-onset symp-
toms) which was in disproportion to the degree of ARF, particularly in
case A. Hematological complications in HVN have rarely been re-
ported so far. Patient A: (24-year old male) was admitted for an acute
inflammatory syndrome (CRP 19.2 mg/dl) with biochemical signs of
diffuse intravascular coagulation (DIC): AP11' 52.9 seconds, D-dimers
8000 ng/ml, platelets 25 x 109/liter, and minor epistaxis. Free plasma-
hemoglobin was 206 ng/liter LDH 562 U/liter, indirect bilirubin 1.66
mg/dl, schistocytes after admission were 3%, but haptoglobin remained
normal. Direct Coombs test with polyvalent antiserum, ANF, ANCA's
cryoglobulines and anti-platelet (auto) antibodies were negative. ARF
developed (peak Sr 5.4 mg%), together with normocytic, normochro-
mic anemia (Hct 27.1%, Hgb 9.6 g/dl). Flowcytometric studies both on
peripheral blood and on bone marrow were within normal limits. Patient
B: (26-year old male) developed ARF (peak Sr 9.7 mg%) accompanied
by severe thrombocytopenia (12 x l09/liter), and normocytic normo-
chromic anemia (Hct 30.6%, Hgb 11.2 g/dl), together with signs of
subclinical DIC (APTT 48.9 sec, PT 59% D-dimers 2000 ng/ml, LDH
432 U/liter). In both patients, internal hemorrhages could be excluded.
Moreover, bone marrow was normocellular in both, with enhanced
megakaryocytosis. All symptoms regressed spontaneously within 10 to
l4 days. Leptospirosis was excluded serologically in each case. In
conclusion, the sum of these data is consistent with microangiopathic
anemia and consumption coagulopathy caused by transcient DIC, prob-
ably as a consequence of HV-induced endothelial lesions. Differential
diagnosis of HVD is warranted in cases oft° with ARF and thrombocyto-
penia, particularly when mucocutaneous hemorrhagic symptoms and
rapid-onset anemia develop concomitantly. The prognosis is good.
The success ofallocating kidneys on the basis of HLA matching is not
the result of HLA matching. E.P.M. van Steenberge, G.P. Pasma, J.
Jeekel, and W. Weimar, Department of Internal Medecine I, Depart-
ment of General Surgery, University Hospital Rotterdam, Rouerdam,
The Netherlands. From July 1983 to December 1990, we performed 345
cadaveric kidney transplantations, with cyclosporin A as the primary
immunosuppressive drug. There were 138 local kidneys, while the
remaining 207 were provided by Eurotransplant (shared kidney). We
examined the effect of sharing kidneys on the incidence of acute
rejection episodes and the number of infections within three months
after transplantation, five years functional graft, patient and graft
survival rates. There were no significant differences in age, gender,
underlying disease, time on dialysis, and the number of retransplanta-
tions between the recipients of local and shared kidneys. In the group of
shared kidneys the donors were predominantly male (71% vs. 52%, P <
0.01), died of trauma capitis (56% vs. 38%, P < 0.01), and had a better
HLA match for class I and class II antigens (mismatch A locus 0.54 vs.
0.82, P < 0.001, mismatch B locus 0.72 vs. 1.1, P < 0.001, mismatch
DR locus 0.39 vs. 0.84, P < 0.001). The cold ischemia time was shorter
for the group of local kidneys (26.4 hrs vs. 30.5 hrs, P <0.001). The age
of the shared donors was considerably lower (34.2 years vs. 37.4 years,P = 0.07). The number of acute rejection episodes and thus the
ACEi months
baseline 2 6 12 18
7.5 0.9 2.9 0.5° 3.1 0.6° 3.5 0.7° 3.5 0.7°
145± 15 149± 16 158±20 165±22° 179÷27ab
wnol/
liter
sK 4.5 0.1 4.8 0.1 5.0 0.1 4.9 0.1 4.9 0.1
mmol/
liter
sAIb 35.0 1.5 37.1 1.1 38.5 0.9° 40.6 l.Ib 41.0 l.l°1'
g/liter
sChol 7.6 0.3 6.7 0.3° 6.8 0.3° 6.8 0.2° 7.1 0.2
g/liter
a p < 0.05 vs. baseline,
"P < 0.05 vs. month 2 of ACEi (Wilcoxon).
The increase in serum creatinine of this group of patients indicates a
decline in kidney function. Individual patients, however, show a wide
variety in rate of renal function deterioration, as measured by their
slope of inverse serum creatinine. Interestingly, a significant correlation
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rejection treatments were significantly lower in the shared kidney group
(27% vs. 43%, P < 0.05). No difference was observed for the number of
infections (local group 48% vs. 43% shared group, NS). The functional
graft survival rates after one to five years were comparable in both
groups (84% vs. 82% at 1 year, 67% vs. 65% at 5 years, NS), while the
incidence of graft loss due to acute or chronic rejection was not different
in both groups (local group 17/36 vs. 22/58 shared group, NS). Also one
year patient survival was comparable (90% vs. 95%, NS). However,
thereafter significant differences in patient survival developed, detri-
mental for the receivers of local kidneys (82% vs. 93% at 2 years, P <
0.01; 62% vs. 81% at 5 years, P < 0.001). This was entirely due to a
higher incidence of cardiovascular deaths (22/33 vs 9/24, P < 0.01). The
graft survival rates in the local group were therefore lower (67% vs. 74%
at 2 years, 48% vs. 56% at 5 years, NS). We conclude that transplan-
tation of kidneys, acquired through an organ exchange organization on
the basis of HLA matching, leads to superior graft survival. This is,
however, not the result of HLA matching, as graft survival is mainly
influenced by non-immunological factors. When patient selection is
based on other criteria than strictly HLA matching (such as dialysis
intolerance), graft survival may be negatively influenced. Nevertheless,
there may be valid reasons to apply these criteria in individual cases.
Retrospective evaluation of the results of therapy for renal allograft
artery stenoses after transplantation. J.W.S. Merkus, F.T.M. Huys-
mans, A.J. Hoitsma, R.A.P. Koene, Department of Nephrology,
University Hospital St. Radboud, Nijmegen, The Netherlands. In a
retrospective analysis of 1165 renal transplantations in our center, 65
cases of renal allograft artery stenosis were diagnosed angiographically
(prevalence 5.5%). Hypertension was present in all cases, whereas a
bruit over the allograft and an increase of serum creatinine level were
additional for angiography. Shortly after diagnosis of the stenosis, two
patients died and two others lost their grafts due to thrombosis. In 24
patients it was decided not to correct the stenosis. One of these grafts
was lost due to the incorrectable stenosis. Medical management of
hypertension in these patients resulted in a decrease of diastolic blood
pressure from 109 22 to 96 12mm Hg (P < 0.01) three months after
diagnosis with the use of twice as many antihypertensive drugs than at
the time of diagnosis (P < 0.01). Correction of the stenosis was
performed if the angiography showed a severe stenosis that jeopardized
renal allograft function or that caused uncontrollable hypertension.
Only three of nine percutaneous transluminal angioplasty (PTA) proce-
dures resulted in a definitive correction of the stenosis. Surgical
intervention was performed in 30 patients, including two patients after
successful PTA. Surgery led to graft loss due to thrombosis in six of 30
operations (20%), whereas re-stenosis occurred twice (7%). In three
other cases (10%) the correction was not successful due to local
anatomical variations or concomitant rejection. Successful correction
of the stenosis by either PTA or surgical intervention (N = 22) resulted
ma significant decrease of systolic (171 31 vs. 145 27mm Hg;P<
0.01) and diastolic (103 15 vs. 89 14 mm Hg; P < 0.05) blood
pressures three months after correction. Concomitantly, a decrease in
the number of antihypertensive drugs from 2.1 1.0 to 1.5 1.0 (P <
0.01) was achieved. In conclusion, renal allograft artery stenosis could
successfully be managed pharmacologically, provided that allograft perfu-
sion was not jeopardized. Successful surgical correction of a stenosis with
effective control of hypertension was achieved in 63% of the cases. PTA
was less frequently successful but did not cause any graft loss.
Amiloride-sensitive lithium reabsorption in rats: Direct assessment by
micropuncture. R. Fransen, W.H. Boer, P. Boer, and H.A. Koomans,
University Hospital Utrecht, Department of Nephrology, Utrecht, The
Netherlands. Data from clearance studies suggest that in rats on a
sodium restricted diet, lithium (Li) reabsorption beyond the proximal
tubules is stimulated. Such distal" Li reabsorption would invalidate
Li-clearance as a measure for proximal water reabsorption. Although
amiloride (Amil) is thought to inhibit distal Li reabsorption without
affecting proximal reabsorption, both distal Li reabsorption and its
abolishment by Amil have never been demonstrated directly. The
current experiments were designed to study fractional reabsorption of
Li in the proximal tubule (FRLi-PCT), the pars recta and loop of Henle
(FRLi-LH) and between LH and urine (FRLi-dist). Late proximal and
early distal tubular fluid samples were collected by micropuncture from
rats fed a 25 mmol Na/kg diet, either without (Cont) or during Amil
infusion (2.4 mg/kg/hr). Li in tubular fluid was determined by atomic
absorption spectrophotometry.
Cont (8) Amil (8) P
FENa % 0.15 0.13 2.17 0.51 <0.01
FEK % 21.1 6.9 0.9 0.5 <0.01
FRLi-PCT % 42.1 5.7 42.5 5.3 0.89
FRLi-LH % 26.5 4.9 31.4 4.8 0.06
FRLi-dist % 10.5 3.5 —0.3 6.8 <0.01
Mean so, 1-test for unpaired observations.
Although FRLi-LH tended to be higher in the Amil group, this
difference was not significant. In the control group an important fraction
of filtered Li is indeed reabsorbed beyond the LH. Amil can abolish this
distal Li reabsorption without any effect on proximal reabsorption.
However, an effect on FRLi-LH cannot be excluded.
Diurnal variation in renal clearance of amylase isoenzymes. W. Smit,
B.A.C. van Acker, G.C.M. Koomen, L. Arisz, Renal Unit, Academic
Medical Center, Amsterdam, The Netherlands. A diurnal variation is
present in glomerular filtration rate (GFR) and urinary protein excre-
tion. We investigated whether the charge selectivity of the glomerular
capillary wall (GCW) is also subject to diurnal variation. We therefore
assessed GCW charge by measuring the clearances of amylase isoen-
zymes which have the same size (2.9 nm) but different charge (pancre-
atic amylase p1 7.0, salivary amylase p1 5.9 to 6.4). During a 24-hour
period, successive three-hour clearances of inulin, p-amylase (CIPAm)
and s-amylase (CISAm) were measured in five healthy volunteers and in
21 patients with renal disease (GFR 21 to 100 mI/mm), of which 15 had
proteinuria. All subjects were in bed and had identical intake of food
and fluid every three hours. Healthy volunteers had CIPAm of 5.3 1.3
mI/mm (mean so) and CISAm of 1.9 1.0 mI/mm. For patients these
values were 2.3 1.3 mI/mm and 1.0 0.4 mI/mm. CIPAm/CISAm ratio
was higher in normals (3.4 1.0 vs. 2.6 1.7, P < 0.05). Time of
maximum was similar for CIPAm, CISAm and GFR, with highest values
during daytime. The relative amplitude (A/M, max to mm as % of mean)
was 29 23% (normals) and 30 33% (patients) for CIPAm. CISAm
had higher A/M: 57 43% and 47 37% (P < 0.01). As a result,
CIPAm/CISAm ratio showed diurnal variation with higher values during
the night compared to daytime (P = 0.05). A/M GFR was 21 11%
(normals) and 21 15% (patients). It is concluded that the ratio of
p-amylase clearance to s-amylase clearance is reduced in patients with
renal disease, indicating reduction in glomerular charge selectivity,
whereas diurnal variation is still present for both isoenzymes. Our
findings of a higher day to night difference for the more anionic
isoenzyme might support the hypothesis that charge selective proper-
ties of GCW are subject to diurnal variation.
Tumor necrosis factor and interleukin-1 induce expression of the
verocytotoxin receptor globotriaosylceramide on human endothelial cells.
N. v.d. Kar. L. Monnens, fvf. Karmali, V. van Hinsbergh, Gaubius
Laboratory, !VVO-TNO, Leiden, The Netherlands; Department of
Pediatrics, St. Radboud Hospital Nymegen, The Netherlands; Depart-
,nent of Microbiology, Hospital for Sick Children, Toronto, Canada.
Infection with verocytotoxin (VT) producing E. coli is the main cause of
the epidemic form of the hemolytic uremic syndrome. The endothelial
cell, which plays an important role in the pathogenesis of the hemolytic
uremic syndrome, is believed to be a putative target for VT. In vitro
studies have demonstrated that endothelial cells become more sensitive
to VT when inflammatory mediators are present. The inflammatory
mediators TNF and IL-i are produced by monocytes and mesangial
cell and may play a local role in the kidney. In this report we
demonstrate the influence of inflammatory mediators on the binding of
VT to the endothelial cells. Preincubation of human umbilical vein and
femoral vein endothelial cells with TNFa for 24 hours results in a ten-
to hundredfold increase of specific binding sites for 251-verocytotoxin- I
('251-VT-l). Furthermore, interleukin-l (IL-I) lymphotoxin and lipo-
polysaccharide also markedly increase VT-I binding. An exposure of
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only six hours to TNFa was already enough to enhance the number of
VT-I binding sites on the endothelial cells for at least two days. In order
to demonstrate that the increase in VT binding was due to an increase
in the functional VT receptor, glycolipid extracts of TNFa-treated cells
were analyzed by thin layer chromatography. An increase of globotri-
aosylceramide (GbOse3cer) was observed, suggesting that preincuba-
tion of human endothelial cells with TNFa leads to increase in
GbOse3cer synthesis in these cells. We conclude from this study that
TNFa and IL-l induce one (or more) enzyme(s) that is (are) rate-
limiting in the synthesis of the glycolipic VT-l receptor, GbOse3cer.
These in vitro studies suggest that in addition to verocytotoxin- I,
inflammatory mediators play an important role in the pathogenesis of
the hemolytic uremic syndrome.
Familial Bartter's syndrome, hypomagnesemia and chondrocalcinosis.
M.!. Koolen, J.F. Haverman, P. Schipper, A.R.M.M. Hermus,
F.J.H.M. v. Liebergen, J.L.J. Jansen, Groot Ziekengasthuis. Den
Bosch, University Hospital NUmegen, The Netherlands. The associa-
tion between Bartter's syndrome (BS) and chondrocalcinosis (CPPD) is
regarded as rare, since only 10 cases have been reported. The hypo-
magnesemia, always present in these patients, is held responsible for
the genesis of CPPD. Familial BS occurs and screening of the family
could lead to an early diagnosis of CPPD. We studied the family of a
70-year-old woman with BS and CPPD: forty-three members (2 gener-
ations) by history-taking and determinations of serum magnesium
(SMg) and potassium (SK). Six other patients were found (three
brothers, two sons and one daughter) with BS and CPPD. The seven
cases all had hypokalemic alkalosis, hypomagnesemia, hyperreninism,
normal blood pressure and excessive 24 hour urinary losses of Mg and
K. X-ray analysis revealed calcifications of the knees, wrists and
symfysis (table). X-ray studies of family members with normal serum
Mg were negative. In conclusion: a family with seven cases of BS with
CPPD is described, all of them magnesium loosing and with significant
calcifications of knees in all seven cases and wrists (5/7) and symfysis
(5/7). Our data are in agreement with a possible role for hypo-
magnesemia in the development of CPPD. It remains to be proven that
correction of the hypomagnesemia cures (improves) CPPD.
Clinical, laboratory and X-ray data
Case no. 7I 2 3 4 5 6
Age 70 66 64 44 39 43 56
Relation a a b c c a
SK mmol/liter 2.4 2.4 3.2 2.5 2.4 2.7 2.9
SMg mmol/liter 0.56 0.60 0.60 0.49 0.54 0.49 0.52
PRAng/ml/min 24 40 8 11 10 11 9
UK mmol/24 hr 56 88 158 56 85 71 —
UMg mmol/24 4.6 3.6 5.0 4.2 3.8 3.7 —
hr
Calcif. knees ++ ++ ++ ++ ++ ++ +++
Calcif. wrists + + + + — — + + + + + +
Calcif. symf. + + — + + + — + + + +
a brother of case 1, b daughter of case I, son of case 1, +, slight;
++, moderate; +++, severe.
Acute pancreatitis in patients on CAPD treatment. M.M. Pannekeet,
R.T. Krediet, E.W. Boeschoten, L. Arisz, Renal Unit, Academic
Medical Center, Amsterdam, The Netherlands. Acute pancreatitis (AP)
in CAPD patients is an infrequent (39 patients world-wide reported) but
serious complication, because of the high mortality of 30.5%. The
incidence of AP during CAPD in the Netherlands is 0.8%, similar to
data from Canada. The diagnosis often is delayed, because the clinical
picture can either be accompanied or masked by peritonitis, or be
confused with it. We reviewed the records of all 16 patients with AP
during CAPD in the Netherlands until this moment. The diagnosis was
made on the basis of a clinical picture (N = 13) or at autopsy (N = 3).
The median interval between the initial symptoms and the diagnosis
was 6.7 days (range I to 30 days) in the first group. Most patients (N =
14) presented with abdominal pain and vomiting but without fever, with
normal peristalsis and with either clear, cloudy or hemorrhagic dialy-
sate. The laboratory results showed elevated WBC in 12 patients
(median 17.6 x l09/liter) and high serum amylase in 13 (median 2458,
range 81 to 8305 U/liter). Amylase in the dialysate was determined in
seven patients and was elevated in all: median 5937, range 3 to 16000
U/liter. One or more risk factors were present in all patients: hyperlip-
idemia (11), hyperparathyroidism (10), hypercalcemia (7), ethanol (1),
previous pancreatitis (1). No cholelithiasis was found. Three patients
recovered on CAPD, four changed to HD and nine patients died, giving
a mortality of 56%. In five patients autopsy was done and revealed
acute hemorrhagic pancreatitis in all. Patients with persistently clear
dialysate had a better prognosis (P < 0.02), whereas in patients with
localized abdominal abnormalities, like (pseudo)cysts and hematoma,
both amylase (P < 0.05) and mortality (P < 0.02) were lower. AP should
be considered in all CAPD patients with a clinical picture of abdominal
pain, nausea and vomiting. The presence of amylase in the dialysate
makes early diagnosis possible. A high index of suspicion is justified in
patients with abdominal pain and hemorrhagic dialysate. AP should also
be considered in patients with abdominal pain, cloudy dialysate nega-
tive culture no reaction on antibiotic therapy. It should even be thought
of in patients with abdominal pain, nausea, vomiting and a clear
dialysate.
Is the diagnostic value of renal scintigraphy for renal artery stenosis
improved by captopril? E. Hoogeveen, A. de Wind, F. Derkx, H. Oey,
H. Pieterman, A. Man in 'tVeld, A. van den Meiracker, E. Krenning,
M. Schalekamp, Departments of Internal Medicine, Radiology, Nu-
clear Medicine, University Hospital Dkzigt Rotterdam, The Nether-
lands. Aim of study and methods: mTcdiethylenetriamine penta-
acetic acid (s9mTcDTPA) renal scintigraphy is used in the diagnostic
work-up of patients with suspected renal artery stenosis (RAS). Here
we report the results in 558 consecutive patients (angiographic diagno-
sis: 247 no stenosis, 200 unilateral stenosis and Ill bilateral stenosis)
enrolled for diagnostic work-up for renovascular hypertension (RVH)
between 1982 and 1992. In 302 patients SSmTcDTpA (1986—1992)
scintigraphy was performed 1 to 4 hours after 50 mg captopril challenge
(25 mg captopril if serum creatinine > 120 mol/liter) (mTcDT
PAcap). In 256 patients (1982—1988) scintigraphy was performed with-
out captopril (mTcDTPA). The aim of the study was to evaluate the
potential usefulness of captopril in this context. Renography was
performed one hour after patients drank 0.5 liter of water. One minute
sequential images were made to generate the split renal function curves.
Single kidney function was estimated from the radioactivity over each
kidney region from the first to the second minute after i.v. injection of
the tracer and was expressed as a percentage of uptake over both
kidneys. Steposis was defined as luminal narrowing of 60% of one of the
main renal arteries. In the patients with bilateral stenosis the most
affected side was taken as the side of stenosis. Results: In patients
without RAS, mTcDTPA uptake on the right side was higher, 53% (46
to 60), mean and (95% confidence interval) than on the left side, 47% (41
to 53), (P < 0.01). The best trade-off points for left (43%) and right
(47%) kidney between sensitivity and specificity were determined from
the Receiver Operator Characteristic Curve, and these results were
compared with the commonly trade-off points of 45%.
Side of
stenosis
Right
99mTCDTPA
uptake%
Sensi
cap—
tivity
cap+
Speci
cap—
ficity
cap+
<45 0.67 0.81 0.93 0.81
Left <45 0.93 0.91 0.66 0.73
Right <47 0.83 0.89 0.87 0.82
Left <43 0.84 0.87 0.77 0.80
Conclusions: (I) One has to account for a normal difference in uptake
between the right and the left side when using mTC.DTPA scintigraphy
for the diagnosis of RAS. With the commonly used trade-off point of
45% for both kidneys, the sensitivity (right kidney) and the specificity
(left kidney) are far from optimal. (2) The diagnostic value of mTc
DTPA scintigraphy is high in a population with a high prevalence of
renal artery stenosis. (3) The diagnostic value of mTcDTPA scintig-
raphy is only slightly improved by captopril. (4) The sensitivity and
specificity, even with captopril, are still not high enough to use
99mTcDTpA scintigraphy as a screeningtest in an unselected popula-
tion with a low prevalence (<10%) of RAS.
